Apellis Pharmaceuticals, Inc. (APLS)
NASDAQ: APLS · Real-Time Price · USD
30.39
+0.92 (3.12%)
Jan 30, 2025, 4:00 PM EST - Market closed
Apellis Pharmaceuticals Analyst Ratings
Total Analysts
18
Consensus Rating
Buy
Price Target
$46.71
Upside
+53.70%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| RBC Capital | RBC Capital | Hold Maintains $26 | Hold | Maintains | $26 | -14.45% | Jan 29, 2025 |
| RBC Capital | RBC Capital | Hold Reiterates $26 | Hold | Reiterates | $26 | -14.45% | Jan 21, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $57 | Strong Buy | Reiterates | $57 | +87.56% | Jan 14, 2025 |
| Goldman Sachs | Goldman Sachs | Strong Buy → Hold Downgrades $36 | Strong Buy → Hold | Downgrades | $36 | +18.46% | Dec 17, 2024 |
| Morgan Stanley | Morgan Stanley | Hold Initiates $31 | Hold | Initiates | $31 | +2.01% | Nov 21, 2024 |
| Baird | Baird | Buy Maintains $92 → $55 | Buy | Maintains | $92 → $55 | +80.98% | Nov 7, 2024 |
| Citigroup | Citigroup | Strong Buy Maintains $63 → $51 | Strong Buy | Maintains | $63 → $51 | +67.82% | Nov 6, 2024 |
| Goldman Sachs | Goldman Sachs | Strong Buy Maintains $71 → $36 | Strong Buy | Maintains | $71 → $36 | +18.46% | Nov 6, 2024 |
| RBC Capital | RBC Capital | Hold Maintains $25 → $24 | Hold | Maintains | $25 → $24 | -21.03% | Nov 6, 2024 |
| Scotiabank | Scotiabank | Hold Maintains $35 → $30 | Hold | Maintains | $35 → $30 | -1.28% | Nov 6, 2024 |
| Wells Fargo | Wells Fargo | Hold Maintains $43 → $30 | Hold | Maintains | $43 → $30 | -1.28% | Nov 6, 2024 |
| Oppenheimer | Oppenheimer | Buy Maintains $65 → $40 | Buy | Maintains | $65 → $40 | +31.62% | Nov 6, 2024 |
| Piper Sandler | Piper Sandler | Hold Maintains $40 → $32 | Hold | Maintains | $40 → $32 | +5.30% | Nov 6, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $83 → $57 | Strong Buy | Maintains | $83 → $57 | +87.56% | Nov 6, 2024 |
| B of A Securities | B of A Securities | Strong Buy Maintains $61 → $47 | Strong Buy | Maintains | $61 → $47 | +54.66% | Nov 6, 2024 |
| Needham | Needham | Strong Buy Maintains $85 → $60 | Strong Buy | Maintains | $85 → $60 | +97.43% | Nov 6, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.